Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 14486

1.

Combined gestational age- and birth weight-adjusted cutoffs for newborn screening of congenital adrenal hyperplasia.

Pode-Shakked N, Blau A, Pode-Shakked B, Tiosano D, Weintrob N, Eyal O, Zung A, Levy-Khademi F, Tenenbaum-Rakover Y, Zangen D, Gillis D, Pinhas-Hamiel O, Loewenthal N, de Vries L, Landau Z, Rachmiel M, Abu-Libdeh A, Eliakim A, Strich D, Koren I, German A, Sack J, Almashanu S.

J Clin Endocrinol Metab. 2019 Mar 13. pii: jc.2018-02468. doi: 10.1210/jc.2018-02468. [Epub ahead of print]

PMID:
30865229
2.

Reference intervals for serum 17α-hydroxyprogesterone and ultrasonographic adrenal gland sizes in healthy newborns.

Karagüzel G, Eyüboğlu İ, Özdem S, Kader Ş, Kaya S, Beyhun NE.

J Matern Fetal Neonatal Med. 2019 Mar 21:1-6. doi: 10.1080/14767058.2019.1594188. [Epub ahead of print]

PMID:
30864869
4.

Congenital Adrenal Hyperplasia-When Clinical Symptoms Are Missing.

Ferraz Liz C, Rocha A.

Pediatr Emerg Care. 2019 Mar 7. doi: 10.1097/PEC.0000000000001752. [Epub ahead of print]

PMID:
30855422
6.

The 11β-hydroxysteroid dehydrogenase isoforms: pivotal catalytic activities yield potent C11-oxy C19 steroids with 11βHSD2 favouring 11-ketotestosterone, 11-ketoandrostenedione and 11-ketoprogesterone biosynthesis.

Gent R, du Toit T, Bloem LM, Swart AC.

J Steroid Biochem Mol Biol. 2019 Feb 27;189:116-126. doi: 10.1016/j.jsbmb.2019.02.013. [Epub ahead of print]

PMID:
30825506
7.

A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.

Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY.

J Pediatr Endocrinol Metab. 2019 Mar 26;32(3):253-258. doi: 10.1515/jpem-2018-0342.

PMID:
30817302
8.

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.

Price JT, Vwalika B, Freeman BL, Cole SR, Mulenga HB, Winston J, Mbewe FM, Chomba E, Mofenson LM, Rouse DJ, Goldenberg RL, Stringer JSA.

BMC Pregnancy Childbirth. 2019 Feb 27;19(1):81. doi: 10.1186/s12884-019-2224-8.

9.

Evaluating the four most important salivary sex steroids during male puberty: testosterone best characterizes pubertal development.

Krebs A, Dickhuth K, Mumm R, Stier B, Doerfer J, Grueninger D, Wurm M, Brichta C, Schwab KO.

J Pediatr Endocrinol Metab. 2019 Mar 26;32(3):287-294. doi: 10.1515/jpem-2018-0451.

PMID:
30811345
10.

Persistence of androgens, progestogens, and glucocorticoids during commercial animal manure composting process.

Zhang JN, Yang L, Zhang M, Liu YS, Zhao JL, He LY, Zhang QQ, Ying GG.

Sci Total Environ. 2019 May 15;665:91-99. doi: 10.1016/j.scitotenv.2019.02.120. Epub 2019 Feb 8.

PMID:
30772582
11.

Biotransformation into 11α-hydroxyprogesterone glucosides by glucosyltransferase.

Yamaguchi T, Lee JH, Lim AR, Yu EJ, Oh TJ.

Steroids. 2019 May;145:32-38. doi: 10.1016/j.steroids.2019.02.008. Epub 2019 Feb 10.

PMID:
30753844
12.

Progestin therapy to prevent preterm birth: History and effectiveness of current strategies and development of novel approaches.

Mesiano SA, Peters GA, Amini P, Wilson RA, Tochtrop GP, van Den Akker F.

Placenta. 2019 Jan 28. pii: S0143-4004(18)31074-9. doi: 10.1016/j.placenta.2019.01.018. [Epub ahead of print] Review.

PMID:
30745115
13.

17α-Hydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy: A Systematic Review and Meta-analysis.

Eke AC, Sheffield J, Graham EM.

Obstet Gynecol. 2019 Mar;133(3):468-475. doi: 10.1097/AOG.0000000000003115.

PMID:
30741815
14.

Estimated Date of Delivery (EDD).

Edwards KI, Itzhak P.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jan 20.

15.

Factors Associated with Utilization of 17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth.

DeNoble AE, Wynn CE, Weaver KE, Wheeler SM, Swamy GK.

Am J Perinatol. 2019 Feb 1. doi: 10.1055/s-0039-1678532. [Epub ahead of print]

PMID:
30708392
16.

Oxidative stress increases the 17,20-lyase-catalyzing activity of adrenal P450c17 through p38α in the development of hyperandrogenism.

Zhu W, Han B, Fan M, Wang N, Wang H, Zhu H, Cheng T, Zhao S, Song H, Qiao J.

Mol Cell Endocrinol. 2019 Mar 15;484:25-33. doi: 10.1016/j.mce.2019.01.020. Epub 2019 Jan 23.

PMID:
30682387
17.

Anti-allodynic and anti-inflammatory effects of 17α-hydroxyprogesterone caproate in oxaliplatin-induced peripheral neuropathy.

Miguel CA, Raggio MC, Villar MJ, Gonzalez SL, Coronel MF.

J Peripher Nerv Syst. 2019 Mar;24(1):100-110. doi: 10.1111/jns.12307. Epub 2019 Feb 25.

PMID:
30680838
18.

Impaired systolic and diastolic left ventricular function in children and adolescents with congenital adrenal hyperplasia receiving corticosteroid therapy.

Tuhan H, Demircan T, Altıncık A, Çatlı G, Kızılca Ö, Egeli T, Kır M, Can Ş, Dündar B, Böber E, Abacı A.

Cardiol Young. 2019 Jan 24:1-6. doi: 10.1017/S1047951118002330. [Epub ahead of print]

PMID:
30675832
19.

A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.

Zhou WB, Chen N, Li CJ.

BMC Endocr Disord. 2019 Jan 23;19(1):14. doi: 10.1186/s12902-019-0342-y.

20.

Gonadal steroids and energy availability during ovarian maturation stages of the Amazonian pirarucu Arapaima gigas (Teleostei: Osteoglossidae) in the wild.

Amaral JS, Venturieri RL, Moreira RG.

Comp Biochem Physiol A Mol Integr Physiol. 2019 Apr;230:106-114. doi: 10.1016/j.cbpa.2019.01.008. Epub 2019 Jan 17.

PMID:
30660680

Supplemental Content

Loading ...
Support Center